Skip to main content
SpringerLink
Log in

Combinations of Cytotoxic Drugs, Ionizing Radiation and EGFR Inhibitors

  • Chapter
Multimodal Concepts for Integration of Cytotoxic Drugs

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 572 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akimoto T, Hunter NR, Buchmiller L, Mason KA, Ang KK, Milas L (1999) Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5:2884–2890

    PubMed  CAS  Google Scholar 

  • Ang KK, Andratschke NH, Milas L (2004) Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58:959–965

    Article  PubMed  CAS  Google Scholar 

  • Balaban N, Moni J, Shannon M, Dang L, Murphy E, Goldkorn T (1996) The effect of Ionizing radiation on signal transduction: antibodies to EGF receptors sensitise A431 cells to radiation. Biochim Biophys Acta 1314:147–156

    Article  PubMed  CAS  Google Scholar 

  • Baselga J, Mendelsohn J (1994) The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 29:127–138

    Article  PubMed  CAS  Google Scholar 

  • Baumann M, Krause M, Zips D, Eicheler W, Doerfler A, Ahrens J, Petersen C, Bruechner K, Hilberg F (2003) Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse. Int J Radiat Biol 79:547–559

    Article  PubMed  CAS  Google Scholar 

  • Buchsbaum DJ, Bonner JA, Grizzle WE, Stackhouse MA, Bohlen P, Raisch KP (2002) Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine and radiation. Int J Radiat Oncol Biol Phys 54:1180–1193

    Article  PubMed  CAS  Google Scholar 

  • Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM, Harari PM (2005) Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res 65:3328–3335

    PubMed  CAS  Google Scholar 

  • Ciardiello F, Bianco R, Damiano V, Lorenzo S de, Pepe S, Placido S de, Fan Z, Mendelsohn J, Bianco AR, Tortora G (1999) Antitumour activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res 5:909–916

    PubMed  CAS  Google Scholar 

  • Contessa JN, Reardon DB, Todd D, Dent P, Mikkelsen RB, Valerie K, Bowers GD, Schmidt-Ullrich RK (1999) The inducible expression of dominant negative epidermal growth factor receptor CD533 results in radiosensitization of human mammary carcinoma cells. Clin Cancer Res 5:405–411

    PubMed  CAS  Google Scholar 

  • Damiano V, Melisi D, Bianco C, Raben D, Caputo R, Fontanini G, Bianco R, Ryan A, Bianco AR, De Placido S, Ciardiello F, Tortora G (2005) Cooperative antitumour effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. Clin Cancer Res 11:5639–5644

    Article  PubMed  CAS  Google Scholar 

  • Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP (2005) Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 280:31182–31189

    Article  PubMed  CAS  Google Scholar 

  • Earp HS, Dawson TL, Li X, Yu H (1995) Heterodimerization and functional interaction between EGF Receptor Family Members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35:115–132

    Article  PubMed  CAS  Google Scholar 

  • Eller JL, Longo SL, Kyle MM, Bassano D, Hicklin DJ, Canute GW (2005) Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Neurosurgery 56:155–162

    PubMed  Google Scholar 

  • Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R (1997) EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 17:613–620

    PubMed  CAS  Google Scholar 

  • Fowler JF (1991) Rapid repopulation in radiotherapy; a debate on mechanism. The phantom of tumour treatment: continually rapid proliferation unmasked. Radiother Oncol 22:156–158

    Article  PubMed  CAS  Google Scholar 

  • Fox SB, Gatter KC, Harris AL (1996) Tumour angiogenesis. J Pathol 179:232–237

    Article  PubMed  CAS  Google Scholar 

  • Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Bridges AJ (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265:1093–1095

    PubMed  CAS  Google Scholar 

  • Giocanti N, Hennequin C, Rouillard D, Defrance R, Favaudon V (2004) Additive interaction of gefitinib (“Iressa”, ZD1839) and Ionizing radiation in human tumour cells in vitro. Br J Cancer 91:2026–2033

    Article  PubMed  CAS  Google Scholar 

  • Giralt J, Eraso A, Armengol M, Rossello J, Majo J, Ares C, Espin E, Benavente S, Torres I de (2002) Epidermal growth factor receptor is a predictor of tumour response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 54:1460–1465

    Article  PubMed  CAS  Google Scholar 

  • Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J (1995) Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumour xenograft model. Clin Cancer Res 1:1311–1318

    PubMed  CAS  Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    Article  PubMed  CAS  Google Scholar 

  • Harari PM, Huang SM (2001) Radiation response modification following molecular inhibition of epidermal growth factor receptor signalling. Semin Radiat Oncol 11:281–289

    Article  PubMed  CAS  Google Scholar 

  • Harari PM, Huang SM (2002) Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development. Semin Radiat Oncol 12:21–26

    Article  PubMed  Google Scholar 

  • Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM, Gill GL, Wiley HS, Cavenee WK (1997) The enhanced tumourigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272:2927–2935

    Article  PubMed  CAS  Google Scholar 

  • Huang SM, Harari PM (2000) Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumour angiogenesis. Clin Cancer Res 6:2166–2174

    PubMed  CAS  Google Scholar 

  • Huang SM, Bock JM, Harari PM (1999) Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 59:1935–1940

    PubMed  CAS  Google Scholar 

  • Huang SM, Li J, Armstrong EA, Harari PM (2002) Modulation of radiation response and tumour-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 62:4300–4306

    PubMed  CAS  Google Scholar 

  • Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP (2000) Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. Clin Cancer Res 6:4874–4884

    PubMed  CAS  Google Scholar 

  • Kashles O, Yarden Y, Fisher R, Ullrich A, Schlessinger J (1991) A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol 11:1454–1463

    PubMed  CAS  Google Scholar 

  • Krause M, Schutze C, Petersen C, Pimentel N, Hessel F, Harstrick A, Baumann M (2005) Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. Radiother Oncol 74:109–115

    Article  PubMed  CAS  Google Scholar 

  • Lammering G, Hewit TH, Hawkins WT, Contessa JN, Reardon DB, Lin PS, Mikkelsen RB, Schmidt-Ullrich RK (2001) Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. J Natl Cancer Inst 93:921–929

    Article  PubMed  CAS  Google Scholar 

  • Magne N, Fischel JL, Dubreuil A, Formento P, Marcie S, Lagrange JL, Milano G (2002) Sequence-dependent effects of ZD1839 (“Iressa”) in combination with cytotoxic treatment in human head and neck cancer. Br J Cancer 86:819–827

    Article  PubMed  CAS  Google Scholar 

  • Mendelsohn J (1997) Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Clin Cancer Res 3:2703–2707

    PubMed  CAS  Google Scholar 

  • Mendelsohn J, Fan Z (1997) Epidermal growth factor receptor family and chemosensitization. J Natl Cancer Inst 89:341–343

    Article  PubMed  CAS  Google Scholar 

  • Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang KK, Mendelsohn J, Fan Z (2000) In vivo enhancement of tumour radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res 6:701–708

    PubMed  CAS  Google Scholar 

  • Modjtahedi H, Affleck K, Stubberfield C, Dean C (1998) EGFR blockade by tyr kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in human squamous cell carcinoma HN5. Int J Oncol 13:335–342

    PubMed  CAS  Google Scholar 

  • Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ (1995) Frequent expression of a mutant epidermal growth factor receptor in multiple human tumours. Cancer Res 55:5536–5539

    PubMed  CAS  Google Scholar 

  • Nakata E, Hunter N, Mason K, Fan Z, Ang KK, Milas L (2004) C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy. Int J Radiat Oncol Biol Phys 59:1163–1173

    Article  PubMed  CAS  Google Scholar 

  • Nyati MK, Maheshwari D, Hanasoge S, Sreekumar A, Rynkiewicz SD, Chinnaiyan AM, Leopold WR, Ethier SP, Lawrence TS (2004) Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res 10:691–700

    Article  PubMed  CAS  Google Scholar 

  • Ogawa J, Iwazaki M, Inoue H, Koide S, Shohtsu A (1993) Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin-sensitivity. Cancer 71:2204–2209

    Article  PubMed  CAS  Google Scholar 

  • Pao W, Miller V, Zakowski M, Doherty J, Ploiti K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H (2004) EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306–13311

    Article  PubMed  CAS  Google Scholar 

  • Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG (2005) Treatment of human tumour xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumour activity. Clin Cancer Res 11:6390–6399

    Article  PubMed  CAS  Google Scholar 

  • Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Dinney CP (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5:257–265

    PubMed  CAS  Google Scholar 

  • Pillai M, Jayaprakash PG, Nair M (1998) Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix. J Cancer Res Clin Oncol 124:456–461

    Article  PubMed  CAS  Google Scholar 

  • Raben D, Helfrich B, Chan D, Shogun T, Zundel W, Scafani R, Bunn P (2001) ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Clin Cancer Res 7:3805–3809

    Google Scholar 

  • Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Baron AE, Zeng C, Johnson TK, Bunn PA Jr (2005) The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res 11:795–805

    PubMed  CAS  Google Scholar 

  • Rao GS, Murray S, Ethier SP (2000) Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. Int J Radiat Oncol Biol Phys 48:1519–1528

    Article  PubMed  CAS  Google Scholar 

  • Reardon DR, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK (1999) Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 18:4756–4766

    Article  PubMed  CAS  Google Scholar 

  • Redemann N, Holzmann B, Rueden TV, Wagner EF, Ullrich A (1992) Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol Cell Biol 12:491–498

    PubMed  CAS  Google Scholar 

  • Riese DJ II, Stern DF (1998) Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20:41–48

    Article  PubMed  Google Scholar 

  • Rodeck U, Jost M, Kari C, Shih DT, Lavker RM, Ewert DL, Jensen PJ (1997) EGFR dependent regulation of keratinocyte survival. J Cell Sci 110:113–121

    PubMed  CAS  Google Scholar 

  • Saleh MN, Raisch KP, Stackhouse MA (1999) Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation. Cancer Biother Radiopharm 14:451–463

    Article  PubMed  CAS  Google Scholar 

  • Santini J, Formento J-L, Francoual M, Milano G, Schneider M, Dassonville O, Demard F (1991) Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13:132–139

    PubMed  CAS  Google Scholar 

  • Schmidt-Ullrich RK, Valerie K, Chan W, McWilliams D (1994) Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 29:813–819

    PubMed  CAS  Google Scholar 

  • Schmidt-Ullrich RK, Valerie K, Fogleman PB, Walters J (1996) Radiation-induced auto-phosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat Res 145:79–83

    Google Scholar 

  • Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K (1999) Signal transduction and cellular radiation responses. Radiat Res 153:245–257

    Article  Google Scholar 

  • Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino GP (2003) Receptor tyrosine kinases and cellular responses to Ionizing radiation. Oncogene Rev 22:5855–5865

    Article  CAS  Google Scholar 

  • Sihto H, Puputti M, Pulli L, Tynninen O, Koskinen W, Aaltonen LM, Tanner M, Bohling T, Visakorpi T, Butzow R, Knuuttila A, Nupponen NN, Joensuu H (2005) Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumours. J Mol Med epub

    Google Scholar 

  • Solomon B, Hagekyriakou J, Trivett MK, Stacker SA, McArthur GA, Cullinane C (2003) EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumour effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Int J Radiat Oncol Biol Phys 55:713–723

    Article  PubMed  CAS  Google Scholar 

  • Stea B, Falsey R, Kislin K, Patel J, Glanzberg H, Carey S, Ambrad AA, Meuillet EJ, Martinez JD (2003) Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 (“Iressa”). Cancer Lett 202:43–51

    Article  PubMed  CAS  Google Scholar 

  • Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK (2005) Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J Biol Chem 280:14597–14604

    Article  PubMed  CAS  Google Scholar 

  • Tanaka T (2005) Inhibition of DNA repair in the radiosensitization of NSCLC cells by gefitinib, a specific EGFR-inhibitor. Proc Am Assoc Cancer Res 46:abstract 1994

    Google Scholar 

  • Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann HP (2005) Radioresistance of K-Ras mutated human tumour cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiother Oncol 76:143–150

    Article  PubMed  CAS  Google Scholar 

  • Weinberg RA (1989) Oncogenes and the molecular origin of cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 54–62

    Google Scholar 

  • Wells A (2000) The epidermal growth factor receptor (EGFR): a new target in cancer therapy. Signal 1:4–11

    Google Scholar 

  • Wikstrand CJ, McLendon RE, Friedman AH, Bigner AD (1997) Cell surface localization and density of the tumour-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res 57:4130–4140

    PubMed  CAS  Google Scholar 

  • Williams KJ, Telfer BA, Stratford IJ, Wedge S (2002) ZD1839 (“Iressa”), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br J Cancer 86:1157–1161

    Article  PubMed  CAS  Google Scholar 

  • Williams KJ, Telfer BA, Brave S, Kendrew J, Whittaker L, Stratford IJ, Wedge SR (2004) ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumour activity. Clin Cancer Res 10:8587–8593

    Article  PubMed  CAS  Google Scholar 

  • Withers HR, Taylor JMG, Maciejewski B (1988) The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

    PubMed  CAS  Google Scholar 

  • Woodburn JR (1999) The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82:241–250

    Article  PubMed  CAS  Google Scholar 

  • Zhou H, Kim YS, Peletier A, McCall W, Earp HS, Sartor CI (2004) Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR-and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance. Int J Radiat Oncol Biol Phys 58:344–352

    Article  PubMed  CAS  Google Scholar 

  • Zhu A, Shaeffer J, Leslie S, Kolm P, El-Mahdi AM (1996) Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumours given definitive irradiation. Int J Radiat Oncol Biol Phys 34:809–815

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology and Laboratory of Experimental Radiation Oncology, University of Maastricht, 6401 CX, Heerlem, The Nerlands

    Guido Lammering MD, PhD

Authors
  1. Guido Lammering MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lammering, G. (2006). Combinations of Cytotoxic Drugs, Ionizing Radiation and EGFR Inhibitors. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation